Rhabdomyosarcoma — Trials

Rhabdomyosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 37
Ph III recruiting: 4
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04854018	Indo-cyanine Green (ICG) in Paediatric Oncology MIS	completed	Phase 4	20	Birmingham Women's and Children's NHS Foundation TrustOTHER	1	Aug 14, 2023	clinicaltrials
NCT00339118	EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children	unknown	Phase 4	—	Sheba Medical CenterOTHER_GOV	0	Jun 20, 2006	clinicaltrials